DE602005019406D1 - Butyrylcholinesteraseselektive inhibitoren - Google Patents

Butyrylcholinesteraseselektive inhibitoren

Info

Publication number
DE602005019406D1
DE602005019406D1 DE602005019406T DE602005019406T DE602005019406D1 DE 602005019406 D1 DE602005019406 D1 DE 602005019406D1 DE 602005019406 T DE602005019406 T DE 602005019406T DE 602005019406 T DE602005019406 T DE 602005019406T DE 602005019406 D1 DE602005019406 D1 DE 602005019406D1
Authority
DE
Germany
Prior art keywords
inhibitors
butyrylcholinesteraseselective
moiety
buche
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005019406T
Other languages
English (en)
Inventor
Gil Ana Martinez
Arrieta Laura Rubio
Ruiz Pilar Munoz
Diaz Isabel Dorronsoro
Palomero Esther Garcia
Monte Millan Maria Del
Padilla Miguel Medina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noscira SA
Original Assignee
Neuropharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuropharma SA filed Critical Neuropharma SA
Publication of DE602005019406D1 publication Critical patent/DE602005019406D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DE602005019406T 2004-05-28 2005-05-27 Butyrylcholinesteraseselektive inhibitoren Active DE602005019406D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04076585A EP1600447A1 (de) 2004-05-28 2004-05-28 Selektive Butyrylcholinesterase Inhibitoren
PCT/EP2005/005816 WO2005118570A1 (en) 2004-05-28 2005-05-27 Butyrylcholinesterase selective inhibitors

Publications (1)

Publication Number Publication Date
DE602005019406D1 true DE602005019406D1 (de) 2010-04-01

Family

ID=34928246

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005019406T Active DE602005019406D1 (de) 2004-05-28 2005-05-27 Butyrylcholinesteraseselektive inhibitoren

Country Status (18)

Country Link
US (1) US20080119521A1 (de)
EP (2) EP1600447A1 (de)
JP (1) JP2008500985A (de)
CN (1) CN1960986A (de)
AT (1) ATE457984T1 (de)
AU (1) AU2005250124B2 (de)
BR (1) BRPI0510865A (de)
CA (1) CA2566594A1 (de)
DE (1) DE602005019406D1 (de)
DK (1) DK1758888T3 (de)
ES (1) ES2340298T3 (de)
IL (1) IL179105A0 (de)
MX (1) MXPA06013783A (de)
PL (1) PL1758888T3 (de)
PT (1) PT1758888E (de)
RU (1) RU2386627C2 (de)
WO (1) WO2005118570A1 (de)
ZA (1) ZA200610127B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060135252A1 (en) * 2004-12-22 2006-06-22 Amaitis Lee M System and method for betting on a subset of participants in an event according to multiple groups
US7435837B2 (en) 2003-10-24 2008-10-14 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
TW201031665A (en) 2009-02-04 2010-09-01 Gruenenthal Gmbh Substituted indole-compound
CN113387867B (zh) * 2021-07-15 2023-03-14 南华大学 一种氨基甲酸酯类邻氨基苯甲酸色胺衍生物及其制备与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
FR2644786B1 (fr) * 1989-03-21 1993-12-31 Adir Cie Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US5428043A (en) * 1990-02-08 1995-06-27 Pfizer Inc. Tricyclic-cyclic amines as novel cholinesterase inhibitors
US5965574A (en) * 1996-08-13 1999-10-12 Chen; Yuhpyng Liang Heteroaryl amines as novel acetylcholinesterase inhibitors
TW263504B (de) * 1991-10-03 1995-11-21 Pfizer
UA67757C2 (uk) * 1997-11-18 2004-07-15 Тейджин Лімітед Похідні циклічних амінів та спосіб інгібування зв'язування хемокіну
WO2001098271A1 (fr) * 2000-06-21 2001-12-27 Eisai Co., Ltd. Compose piperidine 4-substitue
US7838518B2 (en) * 2002-02-12 2010-11-23 N.V. Organon 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders

Also Published As

Publication number Publication date
CA2566594A1 (en) 2005-12-15
WO2005118570A1 (en) 2005-12-15
DK1758888T3 (da) 2010-06-07
BRPI0510865A (pt) 2007-12-26
ES2340298T3 (es) 2010-06-01
MXPA06013783A (es) 2007-08-14
EP1758888B1 (de) 2010-02-17
EP1600447A1 (de) 2005-11-30
AU2005250124B2 (en) 2011-01-06
EP1758888B8 (de) 2010-04-07
ZA200610127B (en) 2008-07-30
RU2386627C2 (ru) 2010-04-20
ATE457984T1 (de) 2010-03-15
RU2006146946A (ru) 2008-07-10
IL179105A0 (en) 2007-03-08
EP1758888A1 (de) 2007-03-07
PT1758888E (pt) 2010-04-29
CN1960986A (zh) 2007-05-09
AU2005250124A1 (en) 2005-12-15
US20080119521A1 (en) 2008-05-22
PL1758888T3 (pl) 2010-07-30
JP2008500985A (ja) 2008-01-17

Similar Documents

Publication Publication Date Title
FR21C1031I1 (de)
CY1112402T1 (el) Ενισχυτες υποδοχεων γλουταμικου
CR9866A (es) Novedosos derivados de 1-aza-bicicloalquilo para el tratamiento de trastornos psicoticos y neurodegenerativos
WO2007079199A3 (en) Substituted bis-amide metalloprotease inhibitors
CY1112630T1 (el) Αναστολεις πυριδυλιου της σηματοδοτησης hedgehog
ATE453393T1 (de) Verwendung von pyridylamiden als angiogenesehemmer
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
CO5570674A2 (es) Derivados de 4-(4-alcoxi-3-hidroxifenil)-2-pirrolidona como inhibidores de pde-4 para el tratamiento de sindromes neurologicos
BRPI0509660A (pt) compostos de beta-carbolina de utilidade no tratamento de doenças inflamatórias
WO2007014762A3 (en) Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
TW200634013A (en) Quinoline derivative, its use, production and pharmaceutical agents containing the derivative
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
PL1723140T3 (pl) Sposób wytwarzania inhibitorów tryptazy
ATE457984T1 (de) Butyrylcholinesteraseselektive inhibitoren
EP1890711A4 (de) Verbindungen für die behandlung oder prävention von mit aminoxidase in zusammenhang stehenden krankheiten oder erkrankungen
ATE547414T1 (de) 4-oxadiazolylpiperidinverbindungen und deren verwendung
UY28601A1 (es) Compuestos quimicos

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: NOSCIRA, S.A., MADRID, ES

8364 No opposition during term of opposition